News For SLXP From The Last 14 Days Check below for free stories on SLXP the last two weeks.
There are 5 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 10, 2012
|
| 12:04 EDT |  | SLXP |
| | 10:29 EDT | | SLXP |
| theflyonthewall.com: | Salix weakness is a buying opportunity, says Caris | | Caris said Salix is down on an FDA draft guidance report for Xifaxan generic requirements. The guidance requires generics only do a clinical study on 200mg for travelers diarrhea, not for 550mg, which is most of Salix's franchise. The firm recommends using Salix weakness as a buying opportunity. Reference Link :theflyonthewall.com |
|
|
February 7, 2012
|
| 07:04 EDT |  | SLXP |
| theflyonthewall.com: | Salix announces FDA granting of priority review designation for Crofelemer | | Salix Pharmaceuticals announced that the U.S. Food and Drug Administration has granted Priority Review designation for the company's New Drug Application for crofelemer 125 mg tablets for the proposed indication for the control and symptomatic relief of diarrhea in patients with human immunodeficiency virus/acquired immune deficiency syndrome on anti-retroviral therapy. :theflyonthewall.com |
|
|
February 6, 2012
|
| 14:22 EDT | | SLXP |
|
|
January 31, 2012
|
| 11:21 EDT |  | SLXP |
|
|
|
Subscribe for More Information